Role of different GnRH agonist regimens in pituitary suppression and the outcome of controlled ovarian hyperstimulation

M Filicori, Marco Filicori, G E Cognigni, Graçiela Estela Cognigni, R. Arnone, Federico Carbone, F Carbone, A Falbo, Angela Falbo, C. Tabarelli, W Ciampaglia, Walter Ciampaglia, P Casadio, Paolo Casadio, Daniela Spettoli, D Spettoli, R. Pecorari
Human Reproduction · 1996 · vol. 11(suppl 3) , pp. 123–132 · doi:10.1093/humrep/11.suppl_3.123 · PMID:9147107 · W2136283467
Review OA: bronze CC0
📄 Open PDF View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-09 ⓘ

This study investigated the role of various GnRH agonist regimens in pituitary suppression and controlled ovarian hyperstimulation, finding that long regimens are most effective for patient scheduling and improving clinical outcomes.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Gonadotrophin-releasing hormone (GnRH) agonists have become irreplaceable addition to gonadotrophins in ovulation induction for assisted reproduction. Of the several schemes currently employed, long regimens appear to be maximally effective to optimize patient scheduling and to improve clinical results.

My notes (saved in your browser only)

MeSH descriptors

Gonadotropin-Releasing Hormone Gonadotropin-Releasing Hormone Gonadotropins Ovulation Induction Ovulation Induction Superovulation Female Gonadotropin-Releasing Hormone Gonadotropins Gonadotropins Humans Superovulation

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (1)

References (56)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T22:00:16.042305+00:00
License: CC0 · commercial use OK